Our previous work showed that a low-molecular-weight (LMW) fucoidan fraction produced venous anti-thrombotic activity in a Wessler model in the rabbit, whereas only a slight anticoagulant effect was observed ex vivo 3, 5 . The present study tested the arterial anti-thrombotic activity of fucoidan in the rabbit and the rat. In conclusion, fucoidan, a polysaccharide of non-mammalian origin that prevents arterial thrombosis without major bleeding in animal models, could be a promising new drug for this pathology. Arterial anti-thrombotic effect of LMW fucoidan, heparin, dalteparin or saline control administered intravenously 5 min before thrombus induction in a rat model of 
